Fluoxetine treatment ameliorates depression induced by perinatal arsenic exposure via a neurogenic mechanism
Authors:
- 1 September 2014
- journal article
- Published by Elsevier in NeuroToxicology
- Vol. 44, 98-109
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health (F31 MH 101984 CRT)
- National Institute of Environmental Health Sciences (RO1ES019583 AMA)
This publication has 80 references indexed in Scilit:
- Adult Hippocampal Neurogenesis and mRNA Expression are Altered by Perinatal Arsenic Exposure in Mice and Restored by Brief Exposure to EnrichmentPLOS ONE, 2013
- Learned helplessness: unique features and translational value of a cognitive depression modelCell and tissue research, 2013
- Glucocorticoid-Related Molecular Signaling Pathways Regulating Hippocampal NeurogenesisNeuropsychopharmacology, 2012
- Dissection of Hippocampal Dentate Gyrus from Adult MouseJournal of Visualized Experiments, 2009
- HDAC2 negatively regulates memory formation and synaptic plasticityNature, 2009
- Long‐lasting depression‐like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercuryJournal of Neurochemistry, 2008
- Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in miceBehavioural Pharmacology, 2005
- Mental health burden amongst inhabitants of an arsenic-affected area in Inner Mongolia, ChinaSocial Science & Medicine, 2004
- Differential regulation of gliogenesis in the context of adult hippocampal neurogenesis in miceGlia, 2004
- Altered Regulation of CREB by Chronic Antidepressant Administration in the Brain of Transgenic Mice with Impaired Glucocorticoid Receptor FunctionNeuropsychopharmacology, 2002